Trial · NCT07912671
Out-Patient Proactive Observation With Wearable-Assisted Tracking for Cardiovascular Health Management
NCT07912671, Not applicable, Not yet recruiting, China National Center for Cardiovascular Diseases
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Out-Patient Proactive Observation With Wearable-Assisted Tracking for Cardiovascular Health Management. Trials, record NCT07912671. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07912671
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Out-Patient Proactive Observation With Wearable-Assisted Tracking for Cardiovascular Health Management
- NCT number
- NCT07912671
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 400 participants, estimated
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Conditions
- Chronic Coronary Syndrome
- Interventions
- Wearable Device-Based Monitoring and LE8 Feedback, Routine Outpatient Care With Data-Blinded Wearable Monitoring
- First posted
- 2026-11-03
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes62
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Life's Essential 8 (LE8) Cardiovascular Health Score | From baseline through 12 months | The primary outcome is the between-group difference in the change in the American Heart Association's Life's Essential 8 (LE8) cardiovascular health score from baseline to 12 months. The LE8 score is calculated automatically by the cloud-based system using data on eight cardiovascular health components: physical activity, sleep health, nicotine exposure, diet, blood pressure, blood glucose, blood lipids, and body mass index. Each component is scored from 0 to 100, and the overall LE8 score is calculated as the unweighted average of the eight component scores, ranging from 0 to 100. Higher scores indicate better cardiovascular health. |
| Secondary | Change in Life's Essential 8 (LE8) Blood Lipids Component Score | From baseline through 12 months | The Life's Essential 8 (LE8) Blood Lipids component score is calculated based on non-high-density lipoprotein cholesterol (non-HDL-C), defined as total cholesterol minus high-density lipoprotein cholesterol (HDL-C), according to the predefined LE8 scoring criteria. The component score ranges from 0 to 100 points, with higher scores indicating better cardiovascular health in the blood lipids domain. The outcome is the between-group difference in the change in this component score from baseline to 12 months. |
| Secondary | Change in Life's Essential 8 (LE8) Blood Glucose Component Score | From baseline through 12 months | The Life's Essential 8 (LE8) Blood Glucose component score is calculated based on blood glucose-related measurements according to the predefined LE8 scoring criteria. The component score ranges from 0 to 100 points, with higher scores indicating better cardiovascular health in the blood glucose domain. The outcome is the between-group difference in the change in this component score from baseline to 12 months. |
| Secondary | Change in Life's Essential 8 (LE8) Blood Pressure Component Score | From baseline through 12 months | The Life's Essential 8 (LE8) Blood Pressure component score is calculated based on measured systolic and diastolic blood pressure according to the predefined LE8 scoring criteria. The component score ranges from 0 to 100 points, with higher scores indicating better cardiovascular health in the blood pressure domain. The outcome is the between-group difference in the change in this component score from baseline to 12 months. |
| Secondary | Change in Life's Essential 8 (LE8) Body Mass Index Component Score | From baseline through 12 months | The Life's Essential 8 (LE8) Body Mass Index component score is calculated based on body mass index (BMI), derived from measured height and weight, according to the predefined LE8 scoring criteria. The component score ranges from 0 to 100 points, with higher scores indicating better cardiovascular health in the body mass index domain. The outcome is the between-group difference in the change in this component score from baseline to 12 months. |
| Secondary | Change in Life's Essential 8 (LE8) Physical Activity Component Score | From baseline through 12 months | The Life's Essential 8 (LE8) Physical Activity component score is calculated based on moderate-to-vigorous physical activity (MVPA), measured using the wearable device according to the predefined LE8 scoring criteria. The component score ranges from 0 to 100 points, with higher scores indicating better cardiovascular health in the physical activity domain. The outcome is the between-group difference in the change in this component score from baseline to 12 months. |
| Secondary | Change in Life's Essential 8 (LE8) Sleep Duration Component Score | From baseline through 12 months | The Life's Essential 8 (LE8) Sleep Duration component score is calculated based on sleep duration measured using the wearable device according to the predefined LE8 scoring criteria. The component score ranges from 0 to 100 points, with higher scores indicating better cardiovascular health in the sleep domain. The outcome is the between-group difference in the change in this component score from baseline to 12 months. |
| Secondary | Change in Life's Essential 8 (LE8) Nicotine Exposure Component Score | From baseline through 12 months | The Life's Essential 8 (LE8) Nicotine Exposure component score is calculated based on nicotine exposure assessed using a standardized questionnaire administered through the mobile application according to the predefined LE8 scoring criteria. The component score ranges from 0 to 100 points, with higher scores indicating better cardiovascular health in the nicotine exposure domain. The outcome is the between-group difference in the change in this component score from baseline to 12 months. |
| Secondary | Change in Life's Essential 8 (LE8) Diet Component Score | From baseline through 12 months | The Life's Essential 8 (LE8) Diet component score is calculated based on dietary information collected using a standardized questionnaire administered through the mobile application according to the predefined LE8 scoring criteria. The component score ranges from 0 to 100 points, with higher scores indicating better cardiovascular health in the dietary domain. The outcome is the between-group difference in the change in this component score from baseline to 12 months. |
| Secondary | LE8 Score ≥80 points | 12 months | Proportion of participants with a Life's Essential 8 (LE8) cardiovascular health score ≥80 points at 12 months. The LE8 score ranges from 0 to 100, with higher scores indicating better cardiovascular health. |
1 to 10 of 62Source ClinicalTrials.gov
See all 62 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07912671
GET https://conductscience.org/api/trials/v1/NCT07912671/registered?page=2